0000950170-24-072996.txt : 20240613
0000950170-24-072996.hdr.sgml : 20240613
20240613160645
ACCESSION NUMBER: 0000950170-24-072996
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240613
DATE AS OF CHANGE: 20240613
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kahn Clare
CENTRAL INDEX KEY: 0001849236
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38360
FILM NUMBER: 241041262
MAIL ADDRESS:
STREET 1: 141 PORTLAND STREET
STREET 2: FIFTH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Solid Biosciences Inc.
CENTRAL INDEX KEY: 0001707502
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 900943402
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 RUTHERFORD AVENUE
STREET 2: 3RD FLOOR
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
BUSINESS PHONE: 617-337-4680
MAIL ADDRESS:
STREET 1: 500 RUTHERFORD AVENUE
STREET 2: 3RD FLOOR
CITY: CHARLESTOWN
STATE: MA
ZIP: 02129
FORMER COMPANY:
FORMER CONFORMED NAME: Solid Biosciences, LLC
DATE OF NAME CHANGE: 20170524
4
1
ownership.xml
4
X0508
4
2024-06-11
0001707502
Solid Biosciences Inc.
SLDB
0001849236
Kahn Clare
C/O SOLID BIOSCIENCES INC.
500 RUTHERFORD AVENUE, THIRD FLOOR
CHARLESTOWN
MA
02129
true
false
false
false
false
Director Stock Option (Right to Buy)
7.51
2024-06-11
4
A
false
34400
0.00
A
2034-06-11
Common Stock
34400
34400
D
This option was granted on June 11, 2024 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
/s/ by David Tyronne Howton as attorney-in-fact for Clare Kahn
2024-06-13